Is it worth adding concurrent chemo-radiotherapy or radiotherapy on the top of neoadjuvant chemotherapy in the management of borderline resectable and locally advanced pancreatic adenocarcinoma? A systematic review

被引:0
|
作者
Saha, A. [1 ]
Wadsley, J. [2 ]
Sirohi, B. [3 ]
Goody, R. [4 ]
Ulahannan, D.
Wilson, D. [5 ]
Collinson, F. [6 ]
Anthony, A. [5 ]
机构
[1] Apollo Gleneagles Canc Hosp, Radiat Oncol, Kolkata, India
[2] Westin Pk Canc Ctr, Clin Oncol, Sheffield, S Yorkshire, England
[3] Apollo Proton Canc Ctr, Dept Med Oncol, Chennai, Karnataka, India
[4] Leeds Canc Ctr, Clin Oncol, Leeds, W Yorkshire, England
[5] Leeds Canc Ctr, Med Oncol, Leeds, W Yorkshire, England
[6] St James Univ Hosp, Oncol Dept, Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England
关键词
D O I
10.1016/j.annonc.2021.08.803
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1476P
引用
收藏
页码:S1090 / S1090
页数:1
相关论文
共 50 条
  • [1] Concurrent chemo-radiotherapy following neoadjuvant chemotherapy in locally advanced breast cancer
    Alberto Alvarado-Miranda
    Oscar Arrieta
    Carlos Gamboa-Vignolle
    David Saavedra-Perez
    Rafael Morales-Barrera
    Enrique Bargallo-Rocha
    Juan Zinser-Sierra
    Victor Perez-Sanchez
    Teresa Ramirez-Ugalde
    Fernando Lara-Medina
    [J]. Radiation Oncology, 4
  • [2] Concurrent chemo-radiotherapy following neoadjuvant chemotherapy in locally advanced breast cancer
    Alvarado-Miranda, Alberto
    Arrieta, Oscar
    Gamboa-Vignolle, Carlos
    Saavedra-Perez, David
    Morales-Barrera, Rafael
    Bargallo-Rocha, Enrique
    Zinser-Sierra, Juan
    Perez-Sanchez, Victor
    Ramirez-Ugalde, Teresa
    Lara-Medina, Fernando
    [J]. RADIATION ONCOLOGY, 2009, 4
  • [3] Chemotherapy for patients with locally advanced pancreatic cancer (LAPC) with additional chemo-radiotherapy (CRT) for patients with borderline resectable tumours
    Bjerregaard, J. K.
    Ladekarl, M.
    Mortensen, M. B.
    Fromm, A. L.
    Pfeiffer, P.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S412 - S412
  • [4] Sequential neoadjuvant chemotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma
    Paluri, Ravi Kumar
    McCormack, Michael Joseph, Jr.
    Neal, Austin
    Moore, Stacie
    Shen, Perry
    Clark, Clancy
    Ogburn, Olivia
    Dressler, Emily Van Meter
    Deep, Gagan
    Greissinger, April
    Mcilwain, Laura
    Yacoub, George
    Sirkisoon, Sherona
    Lima, Caio Max Sao Pedro Rocha
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [5] Neoadjuband Chemo-radiotherapy (NACRT) for Borderline Resectable Pancreatic Cancer
    Kawaguchi, M.
    Takori, K.
    Nakamura, A.
    Uemura, T.
    Mizumoto, M.
    Masui, T.
    Mori, A.
    Okajima, H.
    Hiraoka, M.
    Uemoto, S.
    [J]. PANCREAS, 2014, 43 (08) : 1376 - 1376
  • [6] Chemotherapy and chemo-radiotherapy of advanced pancreatic carcinoma
    Mergenthaler, HG
    Luftner, D
    Possinger, K
    [J]. ONKOLOGIE, 1996, 19 (04): : 308 - 312
  • [7] Neoadjuvant phase II trial of chemo-radiotherapy (CRT) in patients with resectable (R) and borderline resectable (BR) pancreatic ductal adenocarcinoma (PDA)
    Damarla, V.
    Dobrosotskaya, D.
    Siddiqui, F.
    Wollner, I.
    Raoufi, M.
    Li, J.
    Kwon, D.
    Khan, G.
    [J]. EUROPEAN JOURNAL OF CANCER, 2018, 92 : S8 - S9
  • [8] Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma
    Mellon, Eric A.
    Hoffe, Sarah E.
    Springett, Gregory M.
    Frakes, Jessica M.
    Strom, Tobin J.
    Hodul, Pamela J.
    Malafa, Mokenge P.
    Chuong, Michael D.
    Shridhar, Ravi
    [J]. ACTA ONCOLOGICA, 2015, 54 (07) : 979 - 985
  • [9] Neoadjuvant chemotherapy and radiotherapy outcomes in borderline-resectable and locally-advanced pancreatic cancer patients
    Botta, Gregory P.
    Huynh, Tridu R.
    Spierling-Bagsic, Samantha R.
    Agelidis, Alexander
    Schaffer, Randolph
    Lin, Ray
    Sigal, Darren
    [J]. CANCER MEDICINE, 2023, 12 (07): : 7713 - 7723
  • [10] Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma.
    Mellon, Eric Albert
    Hoffe, Sarah E.
    Springett, Gregory M.
    Hodul, Pamela Joy
    Malafa, Mokenge Peter
    Frakes, Jessica M.
    Chuong, Michael D.
    Joel, Tobin
    Strom, Crill
    Shridhar, Ravi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)